Filing Flows › Amphastar Pharmaceuticals (AMPH) › Free cash flow
Amphastar Pharmaceuticals (AMPH) free cash flow by quarter
Amphastar Pharmaceuticals' free cash flow was $33.4M in Q3 2026 (third quarter 2026), -22% from Q2 2026. Over the last 7 quarters it ranged from $24.4M (Q1 2025) to $47.2M (Q3 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $33.4M | -22% | -29% |
| Q2 2026 | $42.7M | +11% | +71% |
| Q1 2026 | $38.3M | +56% | +57% |
| Q4 2025 | $24.6M | -48% | — |
| Q3 2025 | $47.2M | +89% | — |
| Q2 2025 | $25.0M | +3% | — |
| Q1 2025 | $24.4M | — | — |
Q3 2026 at a glance
Amphastar Pharmaceuticals, Q3 2026: revenue $208M (+8% year over year), operating margin 24.5%, net earnings $37.8M, operating cash flow $43.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Amphastar Pharmaceuticals' free cash flow?
Amphastar Pharmaceuticals' free cash flow was $33.4M in Q3 2026 (third quarter 2026), -22% from Q2 2026.
How has Amphastar Pharmaceuticals' free cash flow changed?
Over the last 7 quarters it ranged from $24.4M (Q1 2025) to $47.2M (Q3 2025).
Q3 2026 results → · How Amphastar Pharmaceuticals makes money →